Tyler grew up in Washington State (go Hawks!), where he discovered his passion for chemistry in high school. He began his research career at Western Washington University in Bellingham, Washington. There, he spent several years encouraging conducting polymer/silk-peptide conjugates to self-assemble under the mentorship of Professor Amanda Murphy. Tyler has emerged from the Washington clouds to study chemical biology and immune programming at the University of California, Irvine. So far, Tyler has learned to love the sunny winters, amazing hikes, and avocados of California.
Western Washington University, Bellingham, Washington, 2014
Professor Amanda Murphy
"Follow your passion—you'll be surprised you can change the world. So my advice is: pursue that—leave the world better than you found it . . . " —Bill Nye
Chemical biology, immune programming, and biomaterials.
Tuning Subunit Vaccines with Novel TLR Tri-Agonist Adjuvants to Generate Protective Immune Responses Against Coxiella burnetii.
Adrienne P. Gilkes, Tyler J. Albin, Saikat Manna, Medalyn Supnet, Sara Ruiz, Janine Tom, Alexander J. Badten, Aarti Jain, Rie Nakajima, Jiin Felgner, D. Huw Davies, Samuel A. Stetkevich, Albert Zlotnik, Eric Pearlman, Aysegul Nalca, Philip L. Felgner, Aaron P. Esser-Kahn and Amanda M. Burkhardt. J Immunol February 1, 2020, 204 (3) 611-621; DOI: https://doi.org/10.4049/jimmunol.1900991
Linked Toll-Like Receptor Triagonists Stimulate Distinct, Combination-Dependent Innate Immune Responses
Tyler J Albin, Janine K Tom, Saikat Manna, Adrienne P Gilkes, Samuel A Stetkevich, Benjamin B Katz, Medalyn Supnet, Jiin Felgner, Aarti Jain, Rie Nakajima, Algis Jasinskas, Albert Zlotnik, Eric Pearlman, D Huw Davies, Phillip L Felgner, Amanda M Burkhardt, Aaron P Esser-Kahn. ACS Cent. Sci. 2019, 5, 7, 1137–1145. Jun 27, 2019. doi: 10.1021/acscentsci.8b00823
Bob J. Ignacio, Tyler J. Albin, Aaron P. Esser-Kahn, and Martijn Verdoes. Toll-like Receptor Agonist Conjugation: A Chemical Perspective. Bioconjugate Chemistry. 2018.
Janine Tom, Tyler Albin, Amanda Burkhardt, Philip Felgner and Aaron Esser-Kahn. Development of a tri-agonist compound library used to determine optimal adjuvanticity of a Q fever. The Journal of Immunology. 2016. Vol. 196.
Janine K. Tom, Tyler J. Albin, Saikat Manna, Brittany A. Moser, Rachel C. Steinhardt, Aaron P. Esser-Kahn. Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development. Trends in Biotechnology.